Advertisement

Neurology

Home Neurology

ALS Drug Relyvrio May Be Pulled From Market

Manufacturer may pull medication from the market following lackluster results from a large trial

Degenerative Cervical Myelopathy Patients Often Have Severe Residual Paresthesia

Residual paresthesia tied to significantly worse treatment satisfaction, even after accounting for quality of life

AAN: Three Pesticides Linked to Risk for Parkinson Disease

Highest versus lowest decile of application of simazine, lindane, atrazine linked to increased relative risks for Parkinson disease

Overall Stroke Rates Down, but Hemorrhagic Stroke Up in Recent Years

Overall stroke mortality decline slowed, with variations seen by age and region

Link Between Sleep Apnea, Incident Stroke Examined for Blacks, Whites

Among Whites, high OSA risk, provider-diagnosed sleep apnea, and PAP treatment linked to increased risk for incident stroke

FDA Delays Decision on New Alzheimer’s Drug

By Robin Foster HealthDay Reporter FRIDAY, March 8, 2024 (HealthDay News) -- Instead of approving the new Alzheimer's drug donanemab this month, as was expected,...

FDA Approves Wegovy to Lower Risk for CVD Events in Patients With Obesity

Agency's action could widen access to the drug if more insurance companies decide to cover it

AAN: Dementia More Common With Essential Tremor Than in the General Population

However, dementia rates lower than a comparison cohort of people with Parkinson disease

Risk for MI, Stroke, Death Increased With Plastics in Carotid Plaques

Risk for primary end-point event higher in patients in whom microplastics and nanoplastics were detected within the atheroma

Morphology of Vestibular Aqueduct Linked to Meniere Disease

Correlations seen for VA patency and length with the degree of endolymphatic hydrops in cochlear, vestibule